Skip to content

News & Press Releases

Keep up to date with Teleflex Interventional Urology and related topics. Subscribe here to receive notification of new posts by email.

Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting

April 24, 2025

Experienced Urologists to Present Latest Findings and Host Multiple Educational Sessions WAYNE, Pa., April 24, 2025—Teleflex Incorporated (NYSE:TFX),...

Read More

Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress

March 25, 2025

WAYNE, Pa. – Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from the CLEAR...

Read More

Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types

December 16, 2024

WAYNE, Pa., April 1, 2024 -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full...

Read More

Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting

December 16, 2024

Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign...

Read More

Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged ProstateCompared to Leading Surgical Treatments

November 14, 2023

WAYNE, Pa., November 14, 2023 -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, announced today that a new...

Read More

Teleflex Completes Acquisition of Palette Life Sciences

October 10, 2023

WAYNE, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced...

Read More

New Survey Highlights the Quality of Life Impact of an Enlarged Prostate

September 12, 2023

Men With Bothersome Urinary Symptoms Find Travel Less Enjoyable Due to Frequent Bathroom Needs

Read More

Teleflex to Acquire Palette Life Sciences

July 26, 2023

Acquisition will add Barrigel®, a biodegradable sculptable rectal spacer, to Teleflex’s Interventional Urology portfolio

Read More

New Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients

May 3, 2023

Research Presented at the American Urological Association Annual Meeting Confirms Five-Year Durability of UroLift® System and Highlights Low Rates of...

Read More